Literature DB >> 10521434

The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase.

B V Geisbrecht1, S J Gould.   

Abstract

Human PICD was identified by homology probing the data base of expressed sequence tags with the protein sequence of Saccharomyces cerevisiae Idp3p, a peroxisomal NADP(+)-dependent isocitrate dehydrogenase. The human PICD cDNA contains a 1242-base pair open reading frame, and its deduced protein sequence is 59% identical to yeast Idp3p. Expression of PICD partially rescued the fatty acid growth defect of the yeast idp3 deletion mutant suggesting that PICD is functionally homologous to Idp3p. Kinetic studies on bacterially expressed PICD demonstrated that this enzyme catalyzed the oxidative decarboxylation of isocitrate to 2-oxoglutarate with a specific activity of 22.5 units/mg and that PICD displayed K(M) values of 76 microM for isocitrate and 112 microM for NADP(+). In subcellular fractionation experiments, we found PICD in both peroxisomes and cytoplasm of human and rat liver cells, with approximately 27% of total PICD protein associated with peroxisomes. The presence of PICD in mammalian peroxisomes suggests roles in the regeneration of NADPH for intraperoxisomal reductions, such as the conversion of 2, 4-dienoyl-CoAs to 3-enoyl-CoAs, as well as in peroxisomal reactions that consume 2-oxoglutarate, namely the alpha-hydroxylation of phytanic acid. As for cytoplasmic PICD, the phenotypes of patients with glucose-6-phosphate dehydrogenase deficiency (Luzzatto, L., and Mehta, A. (1995) in The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds) Vol. 3, 7th Ed., pp. 3367-3398, McGraw-Hill Inc., New York) suggest that PICD serves a significant role in cytoplasmic NADPH production, particularly under conditions that do not favor the use of the hexose monophosphate shunt (Luzzatto et al.).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521434     DOI: 10.1074/jbc.274.43.30527

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer.

Authors:  Avaniyapuram Kannan Murugan; Ermal Bojdani; Mingzhao Xing
Journal:  Biochem Biophys Res Commun       Date:  2010-02-18       Impact factor: 3.575

Review 2.  Metabolite transport across the peroxisomal membrane.

Authors:  Wouter F Visser; Carlo W T van Roermund; Lodewijk Ijlst; Hans R Waterham; Ronald J A Wanders
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

Review 3.  Molecular markers of glioma: an update on recent progress and perspectives.

Authors:  Kirti Gupta; Pravin Salunke
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-06       Impact factor: 4.553

4.  Peroxisomal NADP-isocitrate dehydrogenase is required for Arabidopsis stomatal movement.

Authors:  Marina Leterrier; Juan B Barroso; Raquel Valderrama; Juan C Begara-Morales; Beatriz Sánchez-Calvo; Mounira Chaki; Francisco Luque; Benjamin Viñegla; José M Palma; Francisco J Corpas
Journal:  Protoplasma       Date:  2015-04-19       Impact factor: 3.356

5.  The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.

Authors:  Fonnet E Bleeker; Nadia A Atai; Simona Lamba; Ard Jonker; Denise Rijkeboer; Klazien S Bosch; Wikky Tigchelaar; Dirk Troost; W Peter Vandertop; Alberto Bardelli; Cornelis J F Van Noorden
Journal:  Acta Neuropathol       Date:  2010-02-04       Impact factor: 17.088

Review 6.  Sum of the parts: mass spectrometry-based metabolomics.

Authors:  Stephen B Milne; Thomas P Mathews; David S Myers; Pavlina T Ivanova; H Alex Brown
Journal:  Biochemistry       Date:  2013-03-07       Impact factor: 3.162

7.  Dual compartmental localization and function of mammalian NADP+-specific isocitrate dehydrogenase in yeast.

Authors:  Qian Lu; Karyl I Minard; Lee McAlister-Henn
Journal:  Arch Biochem Biophys       Date:  2008-02-06       Impact factor: 4.013

8.  Gene mutations and molecularly targeted therapies in acute myeloid leukemia.

Authors:  Eleftheria Hatzimichael; Georgios Georgiou; Leonidas Benetatos; Evangelos Briasoulis
Journal:  Am J Blood Res       Date:  2013-01-17

Review 9.  Progress on molecular biomarkers and classification of malignant gliomas.

Authors:  Chuanbao Zhang; Zhaoshi Bao; Wei Zhang; Tao Jiang
Journal:  Front Med       Date:  2013-05-17       Impact factor: 4.592

10.  Knockdown of both mitochondrial isocitrate dehydrogenase enzymes in pancreatic beta cells inhibits insulin secretion.

Authors:  Michael J MacDonald; Laura J Brown; Melissa J Longacre; Scott W Stoker; Mindy A Kendrick; Noaman M Hasan
Journal:  Biochim Biophys Acta       Date:  2013-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.